Influence
November 8, 2025

Regenstrief researcher serves as visiting consultant with Emirates Health Services

Regenstrief Institute Research Scientist and Interim Director of the Indiana University Center for Aging Research at Regenstrief, Babar Khan, M.D., M.S., was invited by Emirates Health Services to be a visiting consultant at Ibrahim Bin Hamad Obaidullah Hospital.

During his visit, Dr. Khan conducted rounds and was actively involved in patient care, intensive care unit (ICU) procedures and implementation of care bundles. He streamlined assessments for pain, sedation, agitation and delirium, and provided hands-on training in bronchoscopy and mechanical ventilation practices. Additionally, he delivered two grand rounds focusing on delirium in the ICU and post-intensive care syndrome.

This visiting consultancy was coordinated through the IU Health Destination Services program.

Dr. Khan’s research focuses on delirium in the ICU and the long-term complications experienced by ICU survivors. He has developed and validated a novel tool to assess delirium severity and leads the Critical Care Recovery Center (CCRC), a unique post-ICU clinic that supports patients’ cognitive, physical, and psychological recovery while advancing evidence-based post-ICU research.

Babar Khan, M.D., M.S.
In addition to his role as interim director and research scientist with the Indiana University Center for Aging Research at Regenstrief Institute, Dr. Khan is also a professor of medicine and the Floyd and Reba Smith Professor in Respiratory Disease in the Division of Pulmonary and Critical Care Medicine at Indiana University School of Medicine. In January of 2024, he was appointed the first chief of the newly created Critical Care Section – Indiana Critical Care Management and Recovery Program in the IU Division of Pulmonary, Critical Care, Sleep and Occupational Medicine.

Related News

Regenstrief researcher Jiang Bian named Fellow of ACTS inaugural cohort

Jiang Bian, PhD, of the Regenstrief Institute has been named a 2026 Fellow of the Association for Clinical and Translational Science (ACTS),

Primary Care and Survival: Implications for Research and Policy

Published in the Journal of General Internal Medicine. Here is a link to the article.   Regenstrief Institute authors: David Haggstrom, M.D.,

Regenstrief researcher awarded American Geriatrics Society fellowship

Regenstrief Institute Research Scientist Noll Campbell, PharmD, M.S., has been named one of 11 physicians, pharmacists, researchers and healthcare leaders nationwide